Nanomedicines targeting the inflammasome as a promising therapeutic approach for cell senescence.

Chaturvedi, Swati; Naseem, Zaiba; El-Khamisy, Sherif F; Wahajuddin, Muhammad

Chaturvedi, Swati; Naseem, Zaiba; El-Khamisy, Sherif F; Wahajuddin, Muhammad.

Afiliação

Chaturvedi S; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Richmond Road, Bradford BD7 1DP, United Kingdom.
Naseem Z; Center for Pharmaceutical Engineering Science, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Richmond Road, Bradford BD7 1DP, United Kingdom.
El-Khamisy SF; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Richmond Road, Bradford BD7 1DP, United Kingdom; Healthy Lifespan Institute, School of Biosciences, University of Sheffield, Sheffield S10 2TN, United Kingdom.
Wahajuddin M; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, Richmond Road, Bradford BD7 1DP, United Kingdom. Electronic address: m.wahajuddin@bradford.ac.uk.

Semin Cancer Biol ; 86(Pt 2): 46-53, 2022 11.

Article em En | MEDLINE | ID: mdl-36030027

Assuntos

Nanomedicina; Nanopartículas; Humanos; Inflamassomos; Nanopartículas/uso terapêutico; Sistemas de Liberação de Medicamentos; Senescência Celular

Palavras-chave

Ageing; Drug discovery; Inflammasome; Nanomedicine; Neurodegeneration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanomedicina / Nanopartículas Limite: Humans Idioma: En Revista: Semin Cancer Biol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google